Search
Close this search box.

Viral Vector Manufacturing and Control Strategies

Organization:
United States Pharmacopeial Convention
NIIMBL Funded:
No
Type:
Professional Development / Training
Relevant Technologies:
Analytical Methods / Technologies;Bioprocessing – Upstream;Bioprocessing – Downstream
Delivery Modalities:
Online/E-Learning
Type of Enterprise:
Tier 1/Tier 2
Contact:
Location:
Middle Atlantic
Duration:
0-1 Week
Description:
Viral gene transfer vector manufacturing for in vivo & ex vivo applications has largely been in support of early phase clinical trials, but as product candidates move to later development stages, demand is rapidly increasing for commercial grade vector…